Corpus Intelligence IC Memo — SSH -NORTH KNOXVILLE 2026-04-26 08:02 UTC
IC Memo — SSH -NORTH KNOXVILLE
Investment Committee Memorandum | TN | 65 beds | Grade D | EBITDA uplift $2.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SSH -NORTH KNOXVILLE

CCN 442015 | KNOX, TN | 65 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

SSH -NORTH KNOXVILLE is a 65-bed community hospital in KNOX, TN with $33.7M in net patient revenue and a 0.6% operating margin. The hospital serves a payer mix of 37.3% Medicare, 0.0% Medicaid, and 62.7% commercial.

Thesis: Turnaround. Our ML models identify $2.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 0.6% to 7.9% (+736bps).

Net Revenue HCRIS$33.7M
Current EBITDA COMPUTED$196K
Operating Margin COMPUTED0.6%
Occupancy HCRIS91.3%
Revenue / Bed COMPUTED$519K
Net-to-Gross HCRIS13.8%
Distress Probability MLnan%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
62
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 0.6% places it above the state median. Among 62 size-comparable peers (32-130 beds), the median margin is 0.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (32-130), prioritizing same-state peers. 62 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SSH -NORTH KNOXVILLE (Target)TN65$33.7M0.6%
METRO NASHVILLE GENERAL HOSPITTN114$287.4M48.9%
TRISTAR HENDERSONVILLE MEDICALTN129$208.6M41.5%
TRISTAR STONECREST MEDICAL CENTN115$190.0M39.5%
BAPTIST MEM HOSPITAL TIPTON COTN48$179.0M-5.8%
VANDERBILT WILSON COUNTY HOSPITN113$158.7M-7.1%
SOUTHERN HILLS MEDICAL CENTERTN101$145.2M16.4%
INDIAN PATH COMMUNITY HOSPITALTN35$142.8M12.0%
HORIZON MEDICAL CENTERTN96$141.3M15.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$708K+210bp18mo
Cost to Collect4.5%2.5%$675K+200bp12mo
Denial Rate Reduction12.0%6.5%$668K+198bp12mo
A/R Days Reduction5200.0%3800.0%$410K+122bp9mo
Clean Claim Rate88.0%96.0%$22K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$708K
Cost to Collect
$675K
Denial Rate Reduction
$668K
A/R Days Reduction
$410K
Clean Claim Rate
$22K
Total EBITDA Uplift$2.5M
Current EBITDA$196K
+ RCM Uplift+$2.5M
Pro Forma EBITDA$2.7M
Current Margin0.6%
Pro Forma Margin7.9%
WC Released (1x)$1.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$302K$26.1M86.62x144.1%
Base (11x exit)10.0x11.0x$302K$28.8M95.60x148.9%
Bull Case9.0x11.0x$271K$37.1M136.78x167.4%
Bull (12x exit)9.0x12.0x$271K$40.6M149.51x172.2%
Bear Case11.0x10.0x$332K$13.6M41.03x110.2%
Bear (11x exit)11.0x11.0x$332K$15.1M45.45x114.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 62 hospitals with 32-130 beds
  • Same-state prioritization (n=63)
  • Comp margins: P25=-11.3% / P50=0.8% / P75=12.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.